A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback